A citation-based method for searching scientific literature

Romain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, Anne-Katrin Pröbstel, Orhan Aktas, Harry Alexopoulos, Maria-Pia Amato, Nasrin Asgari, Brenda Banwell, Jeffrey Bennett, Fabienne Brilot, Marco Capobianco, Tanuja Chitnis, Olga Ciccarelli, Kumaran Deiva, Jérôme De Sèze, Kazuo Fujihara, Anu Jacob, Ho Jin Kim, Ingo Kleiter, Hans Lassmann, Maria-Isabel Leite, Christopher Linington, Edgar Meinl, Jacqueline Palace, Friedemann Paul, Axel Petzold, Sean Pittock, Markus Reindl, Douglas Kazutoshi Sato, Krzysztof Selmaj, Aksel Siva, Bruno Stankoff, Mar Tintore, Anthony Traboulsee, Patrick Waters, Emmanuelle Waubant, Brian Weinshenker, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer. Lancet Neurol 2021
Times Cited: 40







List of co-cited articles
323 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Dean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, Philippe Cabre, William Carroll, Tanuja Chitnis, Jérôme de Seze, Kazuo Fujihara, Benjamin Greenberg, Anu Jacob,[...]. Neurology 2015
40

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
S Jarius, F Paul, O Aktas, N Asgari, R C Dale, J de Seze, D Franciotta, K Fujihara, A Jacob, H J Kim,[...]. J Neuroinflammation 2018
343
32

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
Sudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, Tina Kim Nguyen, Vera Merheb, Victor S C Fung, Owen Bruce White, Simon Broadley, Jeannette Lechner-Scott, Steve Vucic,[...]. J Neurol Neurosurg Psychiatry 2018
273
30

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.
Alvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, Bertrand Audoin, Helene Zephir, Bertrand Bourre, Jonathan Ciron, Nicolas Collongues, David Brassat, Francois Cotton,[...]. Neurology 2018
277
27

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
A Sebastian López-Chiriboga, Masoud Majed, James Fryer, Divyanshu Dubey, Andrew McKeon, Eoin P Flanagan, Jiraporn Jitprapaikulsan, Naga Kothapalli, Jan-Mendelt Tillema, John Chen,[...]. JAMA Neurol 2018
148
27

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Sven Jarius, Klemens Ruprecht, Ingo Kleiter, Nadja Borisow, Nasrin Asgari, Kalliopi Pitarokoili, Florence Pache, Oliver Stich, Lena-Alexandra Beume, Martin W Hümmert,[...]. J Neuroinflammation 2016
478
25

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
John J Chen, Eoin P Flanagan, M Tariq Bhatti, Jiraporn Jitprapaikulsan, Divyanshu Dubey, Alfonso Sebastian S Lopez Chiriboga, James P Fryer, Brian G Weinshenker, Andrew McKeon, Jan-Mendelt Tillema,[...]. Neurology 2020
69
25

Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Maciej Jurynczyk, Silvia Messina, Mark R Woodhall, Naheed Raza, Rosie Everett, Adriana Roca-Fernandez, George Tackley, Shahd Hamid, Angela Sheard, Gavin Reynolds,[...]. Brain 2017
317
25

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Vanda A Lennon, Dean M Wingerchuk, Thomas J Kryzer, Sean J Pittock, Claudia F Lucchinetti, Kazuo Fujihara, Ichiro Nakashima, Brian G Weinshenker. Lancet 2004
25

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing.
Elia Sechi, Marina Buciuc, Sean J Pittock, John J Chen, James P Fryer, Sarah M Jenkins, Adrian Budhram, Brian G Weinshenker, A Sebastian Lopez-Chiriboga, Jan-Mendelt Tillema,[...]. JAMA Neurol 2021
30
30

Myelin oligodendrocyte glycoprotein antibodies in neurological disease.
Markus Reindl, Patrick Waters. Nat Rev Neurol 2019
230
20

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Sean J Pittock, Achim Berthele, Kazuo Fujihara, Ho Jin Kim, Michael Levy, Jacqueline Palace, Ichiro Nakashima, Murat Terzi, Natalia Totolyan, Shanthi Viswanathan,[...]. N Engl J Med 2019
300
20

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.
Daniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, Santiago Pardo, Matthew Gornall, Silvia Cicconi, Alexander Brandt, Klaus Berek, Thomas Berger, Ilijas Jelcic,[...]. Mult Scler Relat Disord 2020
55
20

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Yoshiki Takai, Tatsuro Misu, Kimihiko Kaneko, Norio Chihara, Koichi Narikawa, Satoko Tsuchida, Hiroya Nishida, Takashi Komori, Morinobu Seki, Teppei Komatsu,[...]. Brain 2020
71
20

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody.
Romana Höftberger, Yong Guo, Eoin P Flanagan, A Sebastian Lopez-Chiriboga, Verena Endmayr, Sonja Hochmeister, Damir Joldic, Sean J Pittock, Jan Mendelt Tillema, Mark Gorman,[...]. Acta Neuropathol 2020
101
20

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Bruce A C Cree, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier,[...]. Lancet 2019
240
17

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
Vanda A Lennon, Thomas J Kryzer, Sean J Pittock, A S Verkman, Shannon R Hinson. J Exp Med 2005
17

Neuromyelitis optica.
Sven Jarius, Friedemann Paul, Brian G Weinshenker, Michael Levy, Ho Jin Kim, Brigitte Wildemann. Nat Rev Dis Primers 2020
90
17

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
Thaís Armangue, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, Maria Sepulveda, Raquel Ruiz-Garcia, Marta Muñoz-Batista, Helena Ariño, Veronica González-Álvarez, Ana Felipe-Rucián, Maria Jesús Martínez-González,[...]. Lancet Neurol 2020
85
15

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Sudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, Esther M Tantsis, Stephen W Reddel, Andrew P D Henderson, Steve Vucic, Mark P Gorman, Leslie A Benson, Gulay Alper,[...]. Mult Scler 2016
184
15

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
Elia Sechi, Karl N Krecke, Steven A Messina, Marina Buciuc, Sean J Pittock, John J Chen, Brian G Weinshenker, A Sebastian Lopez-Chiriboga, Claudia F Lucchinetti, Nicholas L Zalewski,[...]. Neurology 2021
22
27

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
Tetsuya Akaishi, Toshiyuki Takahashi, Tatsuro Misu, Kimihiko Kaneko, Yoshiki Takai, Shuhei Nishiyama, Ryo Ogawa, Juichi Fujimori, Tadashi Ishii, Masashi Aoki,[...]. Neurology 2021
20
30

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Yael Hacohen, Yu Yi Wong, Christian Lechner, Maciej Jurynczyk, Sukhvir Wright, Bahadir Konuskan, Judith Kalser, Anne Lise Poulat, Helene Maurey, Esther Ganelin-Cohen,[...]. JAMA Neurol 2018
207
15

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Kevin C O'Connor, Katherine A McLaughlin, Philip L De Jager, Tanuja Chitnis, Estelle Bettelli, Chenqi Xu, William H Robinson, Sunil V Cherry, Amit Bar-Or, Brenda Banwell,[...]. Nat Med 2007
242
15

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Masayuki Tahara, Tomoko Oeda, Kazumasa Okada, Takao Kiriyama, Kazuhide Ochi, Hirofumi Maruyama, Hikoaki Fukaura, Kyoichi Nomura, Yuko Shimizu, Masahiro Mori,[...]. Lancet Neurol 2020
101
15

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Marius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, Giovanni Novi, Helen Hayward-Könnecke, Sven Schippling, Paulus S Rommer, Barbara Kornek,[...]. Neurol Neuroimmunol Neuroinflamm 2021
12
50

International multicenter examination of MOG antibody assays.
Markus Reindl, Kathrin Schanda, Mark Woodhall, Fiona Tea, Sudarshini Ramanathan, Jessica Sagen, James P Fryer, John Mills, Bianca Teegen, Swantje Mindorf,[...]. Neurol Neuroimmunol Neuroinflamm 2020
82
12

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Douglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto, Patrick J Waters, Frederico M de Haidar Jorge, Toshiyuki Takahashi, Ichiro Nakashima, Samira Luisa Apostolos-Pereira, Natalia Talim, Renata Faria Simm,[...]. Neurology 2014
524
12

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Joanna Kitley, Patrick Waters, Mark Woodhall, M Isabel Leite, Andrew Murchison, Jithin George, Wilhelm Küker, Saleel Chandratre, Angela Vincent, Jacqueline Palace. JAMA Neurol 2014
376
12

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.
Patrick Waters, Mark Woodhall, Kevin C O'Connor, Markus Reindl, Bethan Lang, Douglas K Sato, Maciej Juryńczyk, George Tackley, Joao Rocha, Toshiyuki Takahashi,[...]. Neurol Neuroimmunol Neuroinflamm 2015
228
12

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein.
Melania Spadaro, Stephan Winklmeier, Eduardo Beltrán, Caterina Macrini, Romana Höftberger, Elisabeth Schuh, Franziska S Thaler, Lisa Ann Gerdes, Sarah Laurent, Ramona Gerhards,[...]. Ann Neurol 2018
81
12

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
Anthony Traboulsee, Benjamin M Greenberg, Jeffrey L Bennett, Lech Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Yusuke Terada, Yuichi Kawata, Padraig Wright,[...]. Lancet Neurol 2020
129
12


Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases.
Pierre Durozard, Audrey Rico, Clémence Boutiere, Adil Maarouf, Romaric Lacroix, Sylvie Cointe, Shirley Fritz, Corinne Brunet, Jean Pelletier, Romain Marignier,[...]. Ann Neurol 2020
61
12

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Patrick Waters, Markus Reindl, Albert Saiz, Kathrin Schanda, Friederike Tuller, Vlastimil Kral, Petra Nytrova, Ondrej Sobek, Helle Hvilsted Nielsen, Torben Barington,[...]. J Neurol Neurosurg Psychiatry 2016
162
12

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
Divyanshu Dubey, Sean J Pittock, Karl N Krecke, Padraig P Morris, Elia Sechi, Nicholas L Zalewski, Brian G Weinshenker, Eslam Shosha, Claudia F Lucchinetti, James P Fryer,[...]. JAMA Neurol 2019
141
12

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Patrick Waters, Giulia Fadda, Mark Woodhall, Julia O'Mahony, Robert A Brown, Denise A Castro, Giulia Longoni, Sarosh R Irani, Bo Sun, E Ann Yeh,[...]. JAMA Neurol 2020
92
12

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Sven Jarius, Hannah Pellkofer, Nadja Siebert, Mirjam Korporal-Kuhnke, Martin W Hümmert, Marius Ringelstein, Paulus S Rommer, Ilya Ayzenberg, Klemens Ruprecht, Luisa Klotz,[...]. J Neuroinflammation 2020
34
14

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Sven Jarius, Imke Metz, Fatima Barbara König, Klemens Ruprecht, Markus Reindl, Friedemann Paul, Wolfgang Brück, Brigitte Wildemann. Mult Scler 2016
78
12

Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder.
A Sebastian Lopez-Chiriboga, Elia Sechi, Marina Buciuc, John J Chen, Sean J Pittock, Claudia F Lucchinetti, Eoin P Flanagan. JAMA Neurol 2020
26
15

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
Tetsuya Akaishi, Douglas Kazutoshi Sato, Ichiro Nakashima, Takayuki Takeshita, Toshiyuki Takahashi, Hiroshi Doi, Kazuhiro Kurosawa, Kimihiko Kaneko, Hiroshi Kuroda, Shuhei Nishiyama,[...]. J Neurol Neurosurg Psychiatry 2016
91
10

Features of MOG required for recognition by patients with MOG antibody-associated disorders.
Caterina Macrini, Ramona Gerhards, Stephan Winklmeier, Lena Bergmann, Simone Mader, Melania Spadaro, Atay Vural, Michaela Smolle, Reinhard Hohlfeld, Tania Kümpfel,[...]. Brain 2021
7
57

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
Giordani Rodrigues Dos Passos, Luana Michelli Oliveira, Bruna Klein da Costa, Samira Luisa Apostolos-Pereira, Dagoberto Callegaro, Kazuo Fujihara, Douglas Kazutoshi Sato. Front Neurol 2018
108
10

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.
Alvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, Thais Armangué, Anne Ruiz, Elisabeth Maillart, Caroline Papeix, Bertrand Audoin, Helene Zephir, Damien Biotti,[...]. J Neuroinflammation 2019
69
10

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.
C L de Mol, Yym Wong, E D van Pelt, Bha Wokke, Tam Siepman, R F Neuteboom, D Hamann, R Q Hintzen. Mult Scler 2020
62
10

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
Claudia F Lucchinetti, Raul N Mandler, Dorian McGavern, Wolfgang Bruck, Gerald Gleich, Richard M Ransohoff, Corinna Trebst, Brian Weinshenker, Dean Wingerchuk, Joseph E Parisi,[...]. Brain 2002
855
10

A multicenter comparison of MOG-IgG cell-based assays.
Patrick J Waters, Lars Komorowski, Mark Woodhall, Sabine Lederer, Masoud Majed, Jim Fryer, John Mills, Eoin P Flanagan, Sarosh R Irani, Amy C Kunchok,[...]. Neurology 2019
98
10

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
Kimihiko Kaneko, Douglas Kazutoshi Sato, Ichiro Nakashima, Ryo Ogawa, Tetsuya Akaishi, Yoshiki Takai, Shuhei Nishiyama, Toshiyuki Takahashi, Tatsuro Misu, Hiroshi Kuroda,[...]. J Neurol Neurosurg Psychiatry 2018
64
10

Evaluation of aquaporin-4 antibody assays.
Patrick J Waters, Sean J Pittock, Jeffrey L Bennett, Sven Jarius, Brian G Weinshenker, Dean M Wingerchuk. Clin Exp Neuroimmunol 2014
78
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.